Avicanna

It’s been three years since Colombia issued Decree 613, regulating cannabis for medical and scientific use across the country. The program has been generally considered successful, and has helped establish a cannabis industry that is leading the region in terms of regulatory development...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Until recently, innovation lay dormant in the quality-driven cannabis industry. However, an evolving regulatory environment, coupled with...

As cannabis businesses in North America attempt to navigate the imminent recession, Colombia’s largest cannabis operators are sharing comments of tranquility in the midst of global market turmoil. Benzinga spoke with leaders at Colombia’s “Big 4” cannabis firms...

Versión en Español en El Planteo: Avicanna Cierra Inversión Privada con el Gigante Farmacéutico Tasly Ontario-based cannabis researcher and producer Avicanna (OTC: AVCNF) announced Tuesday the closing of a private placement deal led by Tasly. Tasly Holding Group Co.,...

First discovered in the 1960s, Cannabigerol (CBG), a once rare, non-psychoactive molecule from which hundreds of other cannabinoids are derived, recently gained momentum as more companies and brands like Avicanna Inc. (OTC: AVCNF) learn of the molecule’s therapeutic benefits in over-the-...

Investors, executives and thought leaders converged at the Fontainebleau Miami Beach resort to network and exchange visions for the cannabis industry at the Benzinga Cannabis Capital Conference this week. Here are 10 companies that made waves at Tuesday’s presentations. urban-gro urban-gro,...

Canopy Growth Corp (NYSE: CGC)’s former CEO Bruce Linton, ousted from his spot earlier this year, said this week he was still buying shares of the company despite his termination. The company's strong cash position, international footprint and extensive intellectual property library are...

Avicanna Inc (TSX: AVCN) announced Friday that its subsidiary, Santa Marta Golden Hemp S.A.S., exported its first batch of purified cannabidiol from Colombia to Canada for scientific research. To enable the import of CBD isolates into Canada, Health Canada issued three authorizations to...

Health Canada has granted biopharmaceutical researcher and cannabis producer Avicanna Inc (TSX: AVCN) with a research license that will allow the company to perform research and intellectual property development on cannabinoids at its facility in the MaRS Discovery District in Toronto. The...

Cannabis researcher and cultivator Avicanna announced a joint venture Thursday with the Canadian full-service testing and research laboratory Sigma Analytical Services Inc. to set up the first cannabis-exclusive analytical facility in South America that Canadian, European, U.S. and EU GMP...

This is the second of a two-part series on the history of Colombia’s troubled past and how it has informed its route to cannabis legalization. It is a hypothetical “Shark Tank” and a well-dressed former Wall Street professional takes the stage to pitch. Sharks, I have the business...

Canadian company Avicanna, a cannabinoid-based products developer, announced Wednesday afternoon it has gained a receipt for its final prospectus filed in connection with its completed special warrant offering for gross proceeds of around C$22.1 million ($16.9 million). The raise was led by Sprott...

The U.S. CBD market could grow to $16 billion in size by 2025, according to Cowen. While the market becomes familiar with CBD, an increase in higher potency cultivars has become a subject of interest in the space. More potent CBD is used by many people — namely those seeking a stronger dose...

Multiple private and public cannabis companies presented their business and outlook to a crowded room during the Benzinga Cannabis Capital Conference April 17-18 in Toronto.  Vertical Companies: Everything But Retail  Vertical Companies is among the largest vertically integrated...

The cannabis space has seen a few large-scale deals in the medical space, but this begs the question: why isn't big pharma much more involved in the industry? Megan Henderson, executive producer of The GrowthOp, moderated a panel of experts Wednesday at the Benzinga Capital Cannabis...